Effect of lovastatin on hemodynamic changes in early stage patients with age-related macular degeneration

International Journal of Ophthalmology

Volumn 9, Issue 8, 2009, Pages 1521-1523

  Mao, Yan Qi ^a   Qi, Xiang Yun ^a   Peng, Wei ^a   Sun, Jian Xi ^a   Wang, Ai Ping ^a  

^a Buji People's Hospital   (China)

Author keywords

Age related macular degeneration; Central retinal artery; Color Doppler flow imaging; Hemodynamics; Lovastatin; Posterior ciliary artery

Indexed keywords

MEVINOLIN; PLACEBO;

ANGIOGENESIS; ARTERY BLOOD FLOW; ARTERY RESISTANCE; ARTICLE; BLOOD FLOW VELOCITY; CILIARY ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; EYE BLOOD FLOW; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HUMAN; MEDIATOR RELEASE; PULSATILE FLOW; RETINA ARTERY; RETINA MACULA AGE RELATED DEGENERATION; SYSTOLE; TREATMENT OUTCOME;

EID: 69949152711     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-5123.2009.08.031     Document Type: Article

References (8)

1. van Leeuwen R, Vingerling JR, Hofmnn A, et al. Cholesterol lowering drugs and risk of age-related maculopathy: prospective cohort study with cumulative exposure measurement. BMJ 2003;326(7383):255-256
2. Mori F, Konno S, Hikichi T, et al. Pulsatile ocular blood flow study: decreases in exudative age related macular degeneration. Br J Ophthalmol 2001;85(5):531-533 (Pubitemid 32397823)
3. van Leeuwen R, IKram MK, Vingerling JR, et al. Blood pressure, atcherosclerosis and the incidence of age-related maculopathy the Rotterdam study. Invest Ophthalmol Vis Sci 2003;44(9):3771-3777 (Pubitemid 37047945)
4. Klein R, Klein BE, Tomany SC, et al. The association of cardio-vascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 2003;110(6):1272-1280 (Pubitemid 36520056)
5. Yildirir A, Muderrisoglu H. Non-lipid effects of statins: emerging new indicutions. Curr Vasc Pharmacol 2004:2(4):309-318 (Pubitemid 39200180)